JP2021525265A5 - - Google Patents
Info
- Publication number
- JP2021525265A5 JP2021525265A5 JP2020565857A JP2020565857A JP2021525265A5 JP 2021525265 A5 JP2021525265 A5 JP 2021525265A5 JP 2020565857 A JP2020565857 A JP 2020565857A JP 2020565857 A JP2020565857 A JP 2020565857A JP 2021525265 A5 JP2021525265 A5 JP 2021525265A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- alkyl
- methyl
- composite according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862676407P | 2018-05-25 | 2018-05-25 | |
| US62/676,407 | 2018-05-25 | ||
| PCT/EP2019/063423 WO2019224340A1 (en) | 2018-05-25 | 2019-05-24 | Pyrrolobenzodiazepine conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021525265A JP2021525265A (ja) | 2021-09-24 |
| JP2021525265A5 true JP2021525265A5 (cg-RX-API-DMAC7.html) | 2022-05-31 |
Family
ID=66677112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565857A Pending JP2021525265A (ja) | 2018-05-25 | 2019-05-24 | ピロロベンゾジアゼピン複合体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210283141A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3801630A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021525265A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112203696A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019224340A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11791309B2 (en) | 2018-12-12 | 2023-10-17 | Heraeus Materials Singapore Pte. Ltd. | Process for electrically connecting contact surfaces of electronic components |
| GB202105186D0 (en) | 2021-04-12 | 2021-05-26 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| GB202105187D0 (en) | 2021-04-12 | 2021-05-26 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| AU2023298568A1 (en) | 2022-06-30 | 2025-01-09 | Toray Industries, Inc. | Pharmaceutical composition for cancer treatment and/or prevention |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58180487A (ja) | 1982-04-16 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | 抗生物質dc−81およびその製造法 |
| ES2260570T3 (es) | 1998-08-27 | 2006-11-01 | Spirogen Limited | Pirrolobenziodiazepinas dimericas. |
| GB0226593D0 (en) | 2002-11-14 | 2002-12-24 | Consultants Ltd | Compounds |
| AU2007351866C1 (en) * | 2003-06-20 | 2013-07-25 | Siga Technologies, Inc. | Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| GB0321295D0 (en) | 2003-09-11 | 2003-10-15 | Spirogen Ltd | Synthesis of protected pyrrolobenzodiazepines |
| ES2398975T3 (es) | 2004-03-01 | 2013-03-25 | Spirogen Sàrl | Derivados de 11-hidroxi-5H-pirrolo[2,1-c][1,4]benzodiazepin-5-ona como intermedios clave para la preparación de pirrolobenzodiazepinas sustituidas en C2 |
| ES2338696T3 (es) | 2005-04-21 | 2010-05-11 | Spirogen Limited | Pirrolobenzodiazepinas. |
| DK1813614T3 (da) | 2006-01-25 | 2012-01-23 | Sanofi Sa | Cytotoksiske midler, der omfatter nye tomaymycinderivater |
| PT2528625E (pt) | 2010-04-15 | 2013-10-17 | Spirogen Sarl | Pirrolobenzodiazepinas e conjugados das mesmas |
| JP6014596B2 (ja) * | 2010-11-09 | 2016-10-25 | メディミューン,エルエルシー | 均一コンジュゲーションのための抗体足場 |
| DK2839860T3 (da) | 2012-10-12 | 2019-06-17 | Medimmune Ltd | Pyrrolobenzodiazepiner og konjugater deraf |
| PT2906253T (pt) * | 2012-10-12 | 2018-11-05 | Medimmune Ltd | Conjugados de anticorpo anti-psma de pirrolobenzodiazepina |
| AU2013366493B2 (en) * | 2012-12-21 | 2017-08-24 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| GB201506389D0 (en) * | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| PE20181302A1 (es) * | 2015-12-04 | 2018-08-09 | Abbvie Stemcentrx Llc | Nuevos anticuerpos anti-claudina y sus metodos de uso |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| AR111963A1 (es) * | 2017-05-26 | 2019-09-04 | Univ California | Método y moléculas |
-
2019
- 2019-05-24 US US17/058,472 patent/US20210283141A1/en not_active Abandoned
- 2019-05-24 EP EP19727612.4A patent/EP3801630A1/en not_active Withdrawn
- 2019-05-24 JP JP2020565857A patent/JP2021525265A/ja active Pending
- 2019-05-24 CN CN201980035410.0A patent/CN112203696A/zh active Pending
- 2019-05-24 WO PCT/EP2019/063423 patent/WO2019224340A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022537158A5 (cg-RX-API-DMAC7.html) | ||
| JP2019536740A5 (cg-RX-API-DMAC7.html) | ||
| JP2024545233A5 (cg-RX-API-DMAC7.html) | ||
| JP2019532056A5 (cg-RX-API-DMAC7.html) | ||
| JP6743015B2 (ja) | Ksp阻害剤の脱グリコシル化抗tweakr抗体との抗体薬物複合体(adc類) | |
| JP6862435B2 (ja) | 抗wt1/hla特異的抗体 | |
| RU2019138337A (ru) | Конъюгаты на основе антитела, содержащие агонист toll-подобного рецептора, и виды комбинированной терапии | |
| ES2815098T3 (es) | Conjugados de ligadores (ADCs) con inhibidores de KSP | |
| RU2476441C2 (ru) | Cd19-связывающие средства и их применение | |
| JP2021527431A5 (cg-RX-API-DMAC7.html) | ||
| JP2024535637A5 (cg-RX-API-DMAC7.html) | ||
| JP2021523147A5 (cg-RX-API-DMAC7.html) | ||
| RU2018119296A (ru) | Конъюгаты антитела, содержащие агонисты толл-подобного рецептора | |
| JP2013056885A5 (cg-RX-API-DMAC7.html) | ||
| JP2018511628A5 (cg-RX-API-DMAC7.html) | ||
| RU2019122802A (ru) | Конъюганты связующего и активного вещества (adc), имеющие ферментативно расщепляемые группы | |
| RU2014124984A (ru) | Конъюгаты антитело-лекарственное средство и родственные соединения, композиции и способы | |
| JP2015535828A5 (cg-RX-API-DMAC7.html) | ||
| JP2023547323A5 (cg-RX-API-DMAC7.html) | ||
| EA039072B1 (ru) | Производные майтанзиноида, их конъюгаты и способы применения | |
| RU2018118061A (ru) | Композиция для лечения рака, экспрессирующего igf-1r | |
| HRP20200032T1 (hr) | Antitijelo lijek konjugati | |
| JP2017528467A5 (cg-RX-API-DMAC7.html) | ||
| CN105641707B (zh) | 细胞毒素分子同细胞结合受体分子的共轭体 | |
| CN119136840A (zh) | 喜树碱类衍生物及配体-药物偶联物 |